Nordic Pharma Consulting ApS: Financial statements 2021
CVR: 37368598
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 8,840,664 and a net result of DKK 1,820,384 compared with DKK 1,519,615 the year before. That is a decrease of 0.6% compared with the year before. Equity in the 2021 report amounted to DKK 2,622,980. The solvency ratio was 51.9%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 8,840,664
- Profit/Loss
- DKK 1,820,384
- Equity
- DKK 2,622,980
- Total Assets
- DKK 5,052,969
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 8.8M | 1.8M | 2.6M | 6 |
| 2020 | - | 8.9M | 1.5M | 2.3M | 5 |
| 2019 | - | 8.6M | 752K | 803K | - |
| 2018 | - | 7M | 493K | 748K | - |
| 2017 | - | 6M | 785K | 855K | - |
Official annual report
Find more companies like Nordic Pharma Consulting ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Nordic Pharma Consulting ApS has published its annual report for 2020. Gross profit came to DKK 8,895,814, and the net result was DKK 1,519,615.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.